EAM Investors, LLC - ADMA BIOLOGICS INC ownership

Quarter-by-quarter ownership
EAM Investors, LLC ownership history of ADMA BIOLOGICS INC
ValueSharesWeighting
Q3 2023$3,462,383
+6.2%
967,146
+9.4%
0.67%
+10.6%
Q2 2023$3,261,377
-4.9%
883,842
-14.7%
0.60%
-10.3%
Q1 2023$3,428,339
-49.5%
1,035,752
-40.8%
0.67%
-52.1%
Q4 2022$6,788,440
+95.7%
1,749,598
+22.6%
1.40%
+86.3%
Q3 2022$3,468,000
+40.3%
1,427,160
+14.3%
0.75%
+25.0%
Q2 2022$2,471,0001,248,1360.60%
Other shareholders
ADMA BIOLOGICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 8,793,321$32,447,35411.70%
Velan Capital Investment Management LP 2,726,051$10,059,1289.34%
Altium Capital Management LP 2,380,000$8,782,2006.65%
AWM Investment Company, Inc. 6,017,572$22,204,8413.01%
Caligan Partners LP 847,513$3,127,3231.76%
Perceptive Advisors 11,900,255$43,911,9411.27%
Mesirow Financial Investment Management, Inc. 51,686$190,7210.81%
OBERWEIS ASSET MANAGEMENT INC/ 1,668,700$6,157,5030.75%
TANG CAPITAL MANAGEMENT LLC 1,260,000$4,649,4000.68%
EAM Investors, LLC 883,842$3,261,3770.60%
View complete list of ADMA BIOLOGICS INC shareholders